Published in Br J Pharmacol on January 01, 1995
Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br J Pharmacol (1995) 1.48
Endothelin. Pharmacol Rev (2016) 0.95
Endothelin receptors in human coronary artery and aorta. Br J Pharmacol (1996) 0.92
Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha 1 subunit protein in rat cerebellar granule cells. Br J Pharmacol (1996) 0.89
Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol (1996) 0.89
Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Br J Pharmacol (1995) 0.85
Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats. Br J Pharmacol (1996) 0.80
Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem (1980) 28.03
Cloning and expression of a cDNA encoding an endothelin receptor. Nature (1991) 7.26
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci (1992) 4.39
A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed (1984) 3.68
Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci (1989) 2.01
Autoradiographical localization of binding sites for porcine [125I]endothelin-1 in humans, pigs, and rats: functional relevance in humans. J Cardiovasc Pharmacol (1989) 1.57
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res (1993) 1.56
Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest (1993) 1.51
Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem Biophys Res Commun (1991) 1.49
Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther (1993) 1.42
Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J Biol Chem (1993) 1.35
Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res (1991) 1.33
Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation (1994) 1.24
Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol (1992) 1.17
Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J (1990) 1.10
Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun (1989) 1.08
Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.05
Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol (1991) 1.04
Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol (1994) 1.01
Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.97
Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue. Eur J Pharmacol (1990) 0.96
A novel subtype of endothelin receptors. J Biol Chem (1992) 0.96
Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun (1993) 0.95
Tissue specificity of the endothelin-induced responses. J Cardiovasc Pharmacol (1991) 0.95
[125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature. Br J Pharmacol (1994) 0.93
Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles. Role of endocardial endothelium. Circ Res (1991) 0.90
Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. Am J Cardiol (1991) 0.88
Localization of endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney. J Cardiovasc Pharmacol (1991) 0.87
Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors. J Pharmacol Exp Ther (1994) 0.86
Multiple subtypes of endothelin receptors in human and porcine tissues: characterization by ligand binding, affinity labeling, and regional distribution. J Cardiovasc Pharmacol (1991) 0.82
Release of endothelin from the porcine heart after short term coronary artery occlusion. Cardiovasc Res (1993) 0.82
Localization of endothelin binding sites and endothelin-like immunoreactivity in human fetal heart. J Cardiovasc Pharmacol (1991) 0.79
Tissue specificity of endothelin binding sites. J Cardiovasc Pharmacol (1990) 0.79
Novel endothelin receptors in the follicular membranes of Xenopus laevis oocytes mediate calcium responses by signal transduction through gap junctions. Mol Pharmacol (1993) 0.78
Characterization of [125I]endothelin-1 binding sites in rat cardiac membrane fragments. J Cardiovasc Pharmacol (1989) 0.76
Regional distribution of endothelin receptor in porcine cardiovascular tissues. Regul Pept (1990) 0.76
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol (2000) 1.78
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res (1993) 1.56
ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol (1995) 1.48
[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol (2001) 1.40
Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J Pharmacol (2011) 1.29
Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int (1993) 1.22
Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol (1992) 1.17
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol (1994) 1.15
Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest (1990) 1.13
[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol (2001) 1.11
Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol (2007) 1.11
Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br J Pharmacol (2001) 1.10
Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res (1996) 1.04
Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol (1994) 1.01
Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle. J Clin Endocrinol Metab (1992) 1.00
Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol (2001) 1.00
Secretory pathways in endothelin synthesis. Br J Pharmacol (1999) 0.98
Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res (1998) 0.97
Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens (1992) 0.95
Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J Cardiovasc Pharmacol (1998) 0.95
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan. Br J Pharmacol (2001) 0.93
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Br J Pharmacol (2009) 0.93
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis (2009) 0.93
Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors. Br J Clin Pharmacol (1998) 0.93
Endothelin receptors in human coronary artery and aorta. Br J Pharmacol (1996) 0.92
Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol (1997) 0.90
Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol (1995) 0.89
Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery. Br J Pharmacol (2001) 0.89
Endothelin receptor subtypes and their functional relevance in human small coronary arteries. Br J Pharmacol (1998) 0.89
Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol (1996) 0.89
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol (1996) 0.89
Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. Circ Res (1999) 0.88
Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol (2010) 0.88
Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem Biophys Res Commun (1993) 0.88
Endothelin receptor antagonism in patients with chronic heart failure. Cardiovasc Res (2000) 0.87
A quantitative 'in-situ' hybridization method using computer-assisted image analysis. Validation and measurement of atrial-natriuretic-factor mRNA in the rat heart. Biochem J (1989) 0.87
Blockade and reversal of endothelin-induced constriction in pial arteries from human brain. Stroke (1999) 0.87
Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated. J Cardiovasc Pharmacol (1993) 0.87
Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol (2001) 0.87
Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors. J Pharmacol Exp Ther (1997) 0.86
Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments. Br J Pharmacol (1996) 0.86
Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro. Br J Pharmacol (2001) 0.86
Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12. Br J Pharmacol (2014) 0.85
Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol (1996) 0.85
Expression of endothelin peptides and mRNA in the human heart. Clin Sci (Lond) (1996) 0.85
Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. Can J Physiol Pharmacol (2002) 0.85
Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Br J Pharmacol (1995) 0.85
Quantification of mRNA in human tissue using fluorescent nested reverse-transcriptase polymerase chain reaction. Anal Biochem (1994) 0.84
Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues. Hum Reprod (1991) 0.84
Endothelin expression in the uterus. J Steroid Biochem Mol Biol (1995) 0.84
Endothelin receptor expression and pharmacology in human saphenous vein graft. Br J Pharmacol (1999) 0.84
Localization of endothelin peptides in human kidney. Kidney Int (1996) 0.84
Localization of endothelin receptors in human uterus throughout the menstrual cycle. Mol Hum Reprod (1996) 0.84
Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. Br J Pharmacol (1995) 0.83
Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery (1998) 0.83
Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. J Cardiovasc Pharmacol (1995) 0.83
Endothelin: progress in pharmacology and physiology. Trends Pharmacol Sci (1993) 0.83
Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies. Placenta (1997) 0.82
Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain. J Cardiovasc Pharmacol (1998) 0.82
Human kidney: endothelin isoforms detected by HPLC with radioimmunoassay and receptor subtypes detected using ligands BQ123 and BQ3020. J Cardiovasc Pharmacol (1993) 0.82
Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme-linked immunosorbent assays. Clin Sci (Lond) (1994) 0.82
Regulation of endothelin receptor expression in vascular smooth-muscle cells. J Cardiovasc Pharmacol (1995) 0.81
Localization of immunoreactive endothelin and proendothelin in the human lung. Pulm Pharmacol (1992) 0.81
Endothelin-A-receptors in human aorta and pulmonary arteries are downregulated in patients with cardiovascular disease: an adaptive response to increased levels of endothelin-1? J Cardiovasc Pharmacol (2000) 0.81
Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors. J Hypertens (1994) 0.81
Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries. Placenta (2003) 0.81
ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242. J Endocrinol (1995) 0.81
Endothelin-like immunoreactivity in human endometrium. J Reprod Fertil (1992) 0.81
Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. Br J Pharmacol (1998) 0.80
Identification of endothelin-1, endothelin-2 and endothelin-3 in human endometrium. J Reprod Fertil (1993) 0.80
Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation. Br J Pharmacol (2006) 0.80
The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis (1990) 0.79
No alteration in vasoconstrictor endothelin-B-receptor density or function in human coronary artery disease. J Cardiovasc Pharmacol (2000) 0.79
Endothelin-2 mRNA splice variants detected by RT-PCR in cultured human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol (1993) 0.78
Localization and endogenous concentration of endothelin-like immunoreactivity in human placenta. J Endocrinol (1991) 0.78
Delineation of endothelin receptors in human left ventricular smooth-muscle cells. J Cardiovasc Pharmacol (1995) 0.78
Changes in ET(A)-, AT1- and AT2-receptors in the phenotypically transformed intimal smooth muscle layer of human atherosclerotic coronary arteries. J Cardiovasc Pharmacol (2000) 0.78
Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans. J Cardiovasc Pharmacol (1995) 0.78
PD156707: a potent antagonist of endothelin-1 in human diseased coronary arteries and vein grafts. J Cardiovasc Pharmacol (1998) 0.77
Syntheses of the first endothelin-A- and -B-selective radioligands for positron emission tomography. J Cardiovasc Pharmacol (2000) 0.77
Novel nitric oxide donors reverse endothelin-1-mediated constriction in human blood vessels. J Cardiovasc Pharmacol (2000) 0.77
Endothelin peptide and converting enzymes in human endothelium. J Cardiovasc Pharmacol (1998) 0.77
Biogenic amines in the brain of the honeybee, Apis mellifera. Cell Tissue Res (1983) 0.77
Distribution of endothelin receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol (1995) 0.77
Endothelin and the human kidney: a potential target for new drugs. Nephrol Dial Transplant (1994) 0.77
In vitro enzymatic processing of radiolabelled big ET-1 in human kidney. Biochem Pharmacol (1998) 0.76
Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b. Brain Res (1992) 0.76
The haemodynamic effects of iodinated water soluble radiographic contrast media: a review. Eur J Radiol (1998) 0.76
Characterization of peptide and nonpeptide antagonists in human kidney. J Cardiovasc Pharmacol (1995) 0.76
Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139. J Cardiovasc Pharmacol (1995) 0.76
Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography. J Cardiovasc Pharmacol (1997) 0.76
Comparative quantification of endothelin receptor mRNA in human kidney: new tools for direct investigation of human tissue. J Cardiovasc Pharmacol (1995) 0.76
Atrial natriuretic factor mRNA and binding sites in the adrenal gland. Biochem J (1990) 0.76
Endothelin-1 stimulates prostaglandin F2 alpha release from human endometrium. Prostaglandins Leukot Essent Fatty Acids (1991) 0.76
Autoradiographic study of endothelin receptors in human cerebral arteries. J Cardiovasc Pharmacol (1995) 0.75
Characterization of site-directed antisera against endothelin-converting enzymes. J Cardiovasc Pharmacol (1998) 0.75
Tissue-specific modulation of endothelin receptors in a rat model of hypertension. J Cardiovasc Pharmacol (2000) 0.75
Sex-related differences in the concentration of Met-enkephalin-like immunoreactivity in the nervous system of an insect, Schistocerca gregaria, revealed by radioimmunoassay. Brain Res (1986) 0.75